JP2025501775A5 - - Google Patents

Info

Publication number
JP2025501775A5
JP2025501775A5 JP2024539010A JP2024539010A JP2025501775A5 JP 2025501775 A5 JP2025501775 A5 JP 2025501775A5 JP 2024539010 A JP2024539010 A JP 2024539010A JP 2024539010 A JP2024539010 A JP 2024539010A JP 2025501775 A5 JP2025501775 A5 JP 2025501775A5
Authority
JP
Japan
Prior art keywords
antibody
antigen
binding fragment
amino acid
substantially similar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024539010A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025501775A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/082428 external-priority patent/WO2023129928A2/en
Publication of JP2025501775A publication Critical patent/JP2025501775A/ja
Publication of JP2025501775A5 publication Critical patent/JP2025501775A5/ja
Pending legal-status Critical Current

Links

JP2024539010A 2021-12-27 2022-12-27 SARS-CoV-2のスパイクタンパク質に対して特異的な抗体及びその使用 Pending JP2025501775A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163266008P 2021-12-27 2021-12-27
US63/266,008 2021-12-27
PCT/US2022/082428 WO2023129928A2 (en) 2021-12-27 2022-12-27 Antibody specific to spike protein of sars-cov-2 and uses thereof

Publications (2)

Publication Number Publication Date
JP2025501775A JP2025501775A (ja) 2025-01-23
JP2025501775A5 true JP2025501775A5 (https=) 2025-02-06

Family

ID=87000251

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024539010A Pending JP2025501775A (ja) 2021-12-27 2022-12-27 SARS-CoV-2のスパイクタンパク質に対して特異的な抗体及びその使用

Country Status (6)

Country Link
US (1) US20230279080A1 (https=)
EP (1) EP4457243A4 (https=)
JP (1) JP2025501775A (https=)
CN (1) CN120787235A (https=)
TW (1) TW202342511A (https=)
WO (1) WO2023129928A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180128545A1 (en) 2016-11-08 2018-05-10 Berry Metal Company Modular furnace cooling wall
US12384811B2 (en) 2019-04-05 2025-08-12 Academia Sinica Sialidase-resistant saccharide and method of making and using the same
TWI870591B (zh) 2020-05-08 2025-01-21 中央研究院 嵌合流感疫苗
BR112023000666A2 (pt) 2021-04-12 2023-10-24 Academia Sinica Imunógeno, composição imunogênica, método para induzir uma resposta imune contra um coronavírus 2 da síndrome respiratória aguda grave e uso da composição imunogênica
TW202334429A (zh) 2021-10-01 2023-09-01 中央研究院 Sars-cov-2棘蛋白特異性抗體及其用途
AU2024252371B2 (en) 2023-04-08 2026-02-12 Rock Biomedical Inc. Methods and compositions for dendritic cell targeting nano-delivery
US12318485B2 (en) 2023-04-08 2025-06-03 Rock Biomedical, Inc. Methods and compositions for targeted delivery by polymersomes
WO2024238734A2 (en) 2023-05-17 2024-11-21 Rock Biomedical Inc. Mgat1 deficient cells and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2014681A1 (en) * 2007-07-12 2009-01-14 Pierre Fabre Medicament Novel antibodies inhibiting c-met dimerization, and uses thereof
RU2011111640A (ru) * 2008-08-29 2012-10-10 Симфоген А/С (Dk) Антитела против cd5
EP3347048B1 (en) * 2015-09-09 2020-04-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Antibodies having specificity to nectin-4 and uses thereof
WO2017062496A2 (en) * 2015-10-05 2017-04-13 University Of Virginia Patent Foundation Anti-sas1b antibodies, associated methods of use, and compositions and methods for detecting and treating cancer
AU2018312563A1 (en) * 2017-08-01 2020-03-12 City Of Hope Anti-IL1RAP antibodies
CN110713537B (zh) * 2018-07-13 2023-04-21 江苏怀瑜药业有限公司 一种sema4d抗体及其制备方法和应用
KR20250107297A (ko) * 2020-04-02 2025-07-11 리제너론 파아마슈티컬스, 인크. 항-sars-cov-2 스파이크 당단백질 항체 및 항원-결합 단편

Similar Documents

Publication Publication Date Title
JP2025501775A5 (https=)
JP2024109678A5 (https=)
JP2021526022A5 (https=)
JP2020152735A5 (https=)
JP2022075818A5 (https=)
RU2009129403A (ru) Антитела, нейтрализующие цитомегаловирус человека, и их применение
JP2021521843A5 (https=)
RU2011105062A (ru) Нейтрализующие антитела против вируса гриппа а и их использование
RU2588467C3 (ru) Стабильные и растворимые антитела, ингибирующие vegf
RU2012112829A (ru) Анти-gitr-антитела
JP2010516229A5 (https=)
JP2011528902A5 (https=)
JP2015534982A5 (https=)
JP2023093753A5 (https=)
JP2020501598A5 (https=)
RU2012103212A (ru) Tlr3 связывающие агенты
JP2024542194A5 (https=)
JP2020522280A5 (https=)
JP2021501579A5 (https=)
JP2020522281A5 (https=)
JP2021517459A5 (https=)
JP2024024114A5 (https=)
JP2024540148A5 (https=)
JP2025508066A5 (https=)
JP2024538148A5 (https=)